Literature DB >> 6189119

Interferon-mediated inhibition of virus penetration.

P A Whitaker-Dowling, D K Wilcox, C C Widnell, J S Youngner.   

Abstract

Pretreatment of mouse L cells with mouse interferon (IFN) inhibits the penetration of vesicular stomatitis virus without affecting viral adsorption. The inhibition of virus uptake by IFN is dose dependent and, at the highest dose tested (1,000 units/ml), reaches 65%; 24 hr of treatment with IFN are required for maximal effect. A similar inhibition of uptake of virus occurs in human diploid fibroblasts and primary chicken embryo fibroblasts treated with homologous IFN. No significant inhibition occurs when cells are treated with heterologous IFN. These results document a previously unrecognized antiviral effect of IFN--namely, inhibition at the level of viral uptake.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189119      PMCID: PMC393532          DOI: 10.1073/pnas.80.4.1083

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Inhibition of the infectivity of poliovirus ribonucleic acid by an interferon.

Authors:  M HO
Journal:  Proc Soc Exp Biol Med       Date:  1961-07

2.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

3.  Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon.

Authors:  R M Friedman; J M Ramseur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

4.  Viropexis of vesicular stomatitis virus by L cells.

Authors:  R W Simpson; R E Hauser; S Dales
Journal:  Virology       Date:  1969-02       Impact factor: 3.616

5.  Quantitative aspects of inhibition of virus replication by interferon in chick embryo cell cultures.

Authors:  J V Hallum; J S Younger
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

6.  Electrophoretic profiles and activities of human interferon in heterologous cells.

Authors:  L Borecký; N Fuchsberger; V Hajnická
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

Review 7.  Action of interferon and its inducers aginst nonviral infectious agents.

Authors:  J Vilcek; R I Jahiel
Journal:  Arch Intern Med       Date:  1970-07

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Inhibition of TRIC agents by virus-induced interferon.

Authors:  L Hanna; T C Merigan; E Jawetz
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

10.  Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase.

Authors:  P I Marcus; D L Engelhardt; J M Hunt; M J Sekellick
Journal:  Science       Date:  1971-11-05       Impact factor: 47.728

View more
  17 in total

1.  Robust kinetics of an RNA virus: Transcription rates are set by genome levels.

Authors:  Collin Timm; Ankur Gupta; John Yin
Journal:  Biotechnol Bioeng       Date:  2015-05-20       Impact factor: 4.530

2.  Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein.

Authors:  P Staeheli; J Pavlovic
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence.

Authors:  Emily A Voigt; John Yin
Journal:  J Interferon Cytokine Res       Date:  2015-05-04       Impact factor: 2.607

4.  Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

Authors:  J D Fingeroth; M L Clabby; J D Strominger
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

5.  Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-alpha): immediate antiviral activity of IFN-alpha during the early phase of infection.

Authors:  A X Delcayre; M Lotz; W Lernhardt
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Interferon treatment inhibits pinocytosis.

Authors:  D K Wilcox; P A Whitaker-Dowling; J S Youngner; C C Widnell
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

7.  Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.

Authors:  R C Hom; G Soman; R Finberg
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Effect of mouse lymphokines and cloned mouse interferon-gamma on the interaction of Rickettsia prowazekii with mouse macrophage-like RAW264.7 cells.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus.

Authors:  Brooke L Carey; Maryam Ahmed; Shelby Puckett; Douglas S Lyles
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  Interferon stimulates cholesterol and phosphatidylcholine synthesis but inhibits cholesterol ester synthesis in HeLa-S3 cells.

Authors:  L M Pfeffer; B C Kwok; F R Landsberger; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.